Header Logo

Connection

Jennifer Ku to Humans

Back to Details
This is a "connection" page, showing publications Jennifer Ku has written about Humans.
Jennifer Ku
Connection Strength
1.012
Humans
  1. Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults =65 Years of Age. Clin Infect Dis. 2024 Nov 22; 79(5):1283-1292.
    View in: PubMed
    Score: 0.067
  2. Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System. Am J Ophthalmol. 2024 07; 263:133-140.
    View in: PubMed
    Score: 0.064
  3. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Chest. 2024 May; 165(5):1058-1069.
    View in: PubMed
    Score: 0.063
  4. Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study. Vaccine. 2023 06 29; 41(29):4212-4219.
    View in: PubMed
    Score: 0.061
  5. Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study. Vaccine. 2023 06 01; 41(24):3636-3646.
    View in: PubMed
    Score: 0.061
  6. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Clin Infect Dis. 2023 02 08; 76(3):e1408-e1415.
    View in: PubMed
    Score: 0.060
  7. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clin Infect Dis. 2023 01 13; 76(2):338-341.
    View in: PubMed
    Score: 0.059
  8. Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States. Chest. 2022 02; 161(2):365-369.
    View in: PubMed
    Score: 0.054
  9. Limited Validity of Diagnosis Code-based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data. Ann Am Thorac Soc. 2021 07; 18(7):1246-1249.
    View in: PubMed
    Score: 0.053
  10. Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients. Emerg Infect Dis. 2021 03; 27(3):982-985.
    View in: PubMed
    Score: 0.052
  11. 'Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis. Diagn Microbiol Infect Dis. 2020 Feb; 96(2):114916.
    View in: PubMed
    Score: 0.047
  12. Determinants of Patient Satisfaction in an Academic Rheumatology Practice. J Clin Rheumatol. 2015 Aug; 21(5):256-62.
    View in: PubMed
    Score: 0.035
  13. Implications for biologic therapy: Staphylococcus aureus decolonization of individuals with a history of recurrent skin and soft-tissue infections. JAMA Dermatol. 2013 Aug; 149(8):986-9.
    View in: PubMed
    Score: 0.031
  14. Characteristics and visual outcome of patients with retinal vasculitis. Arch Ophthalmol. 2012 Oct; 130(10):1261-6.
    View in: PubMed
    Score: 0.029
  15. Development and validation of prediction algorithm to identify tuberculosis in two large California health systems. Nat Commun. 2025 Apr 10; 16(1):3385.
    View in: PubMed
    Score: 0.017
  16. Comparative Effectiveness of Cell-Based Versus Egg-Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022-2023 Season Among Adults 18-64?Years. Influenza Other Respir Viruses. 2024 Dec; 18(12):e70025.
    View in: PubMed
    Score: 0.017
  17. Risk Factors for Recurrent Urinary Tract Infections Among Women in a Large Integrated Health Care Organization in the United States. J Infect Dis. 2024 Nov 15; 230(5):e1101-e1111.
    View in: PubMed
    Score: 0.017
  18. Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2335052.
    View in: PubMed
    Score: 0.016
  19. Development of a University-Government Partnership for Public Health Response and Workforce Development in the State of Oregon. J Community Health. 2024 Oct; 49(5):779-784.
    View in: PubMed
    Score: 0.016
  20. Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged =50 years in the United States. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2327145.
    View in: PubMed
    Score: 0.016
  21. mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States. Nat Commun. 2023 09 20; 14(1):5851.
    View in: PubMed
    Score: 0.016
  22. Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults. Clin Infect Dis. 2023 01 13; 76(2):252-262.
    View in: PubMed
    Score: 0.015
  23. Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat Commun. 2023 Jan 12; 14(1):189.
    View in: PubMed
    Score: 0.015
  24. Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):643-649.
    View in: PubMed
    Score: 0.015
  25. Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study. PLoS One. 2022; 17(4):e0267824.
    View in: PubMed
    Score: 0.014
  26. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ. 2021 12 15; 375:e068848.
    View in: PubMed
    Score: 0.014
  27. COVID-19 pandemic management and the rheumatology patient. Best Pract Res Clin Rheumatol. 2021 03; 35(1):101663.
    View in: PubMed
    Score: 0.013
  28. Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria. Ann Am Thorac Soc. 2017 Jul; 14(7):1112-1119.
    View in: PubMed
    Score: 0.010
  29. Long-Term Outcomes in a Population-based Cohort with Respiratory Nontuberculous Mycobacteria Isolation. Ann Am Thorac Soc. 2017 07; 14(7):1120-1128.
    View in: PubMed
    Score: 0.010
  30. Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007-2012. Emerg Infect Dis. 2017 03; 23(3):533-535.
    View in: PubMed
    Score: 0.010
  31. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. Eur Respir J. 2015 Apr; 45(4):1177-9.
    View in: PubMed
    Score: 0.009
  32. Triple antibiotic combination therapy may improve but not resolve granuloma annulare. Dermatol Ther. 2014 Nov-Dec; 27(6):343-7.
    View in: PubMed
    Score: 0.008
  33. The course of retinal vasculitis. Br J Ophthalmol. 2014 Jun; 98(6):785-9.
    View in: PubMed
    Score: 0.008
  34. Multimodality endoscopic treatment of pancreatic duct disruption with stenting and pseudocyst drainage: how efficacious is it? Dig Liver Dis. 2013 Feb; 45(2):129-33.
    View in: PubMed
    Score: 0.007
  35. Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol. 2013 Jan; 155(1):183-189.e1.
    View in: PubMed
    Score: 0.007
  36. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum. 2012 Jun; 41(6):859-65.
    View in: PubMed
    Score: 0.007

© 2025 Kaiser Permanente

Your Privacy Choices